The Current Treg Landscape for Autoimmune Diseases, Recent Deals & Emerging Companies

10:15 am - Thursday 26th March 2026

  • Examine how Treg-directed therapies are reshaping treatment of autoimmune diseases
  • Survey the leading Treg clinical trials testing immune tolerance in the clinic
  • Highlight recent deals and the key players driving the Treg therapeutic landscape

Speakers:

senior researcher
Beacon